Cargando…
A case report of severe hyponatremia secondary to Paxlovid‐induced SIADH
Nirmatrelvir‐ritonavir (Paxlovid) is a brand‐new oral antiviral medication for treating mild to severe COVID‐19. The Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for ritonavir‐nirmatrelvir on December 22, 2021, to treat COVID‐19. We describe a case of mild COVID‐19...
Autores principales: | Mohamed, Sarah, Reda Mostafa, Mostafa, Magdi Eid, Mohamed, AbdelQadir, Yossef Hassan, Abdelghafar, Yomna Ali, Swed, Sarya, Jahshan, Bishara, El‐Radi, Waddah Abd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465720/ https://www.ncbi.nlm.nih.gov/pubmed/37655131 http://dx.doi.org/10.1002/ccr3.7860 |
Ejemplares similares
-
Subdural empyema due to mixed infections successfully treated medically: A case report with review literature
por: Meshref, Mostafa, et al.
Publicado: (2022) -
Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials
por: Abdelghafar, Yomna Ali, et al.
Publicado: (2022) -
Prevalence and patterns of premenstrual disorders and possible association with sexual harassment: a cross-sectional study of young Arab women
por: AbdelQadir, Yossef Hassan, et al.
Publicado: (2022) -
Brucellosis manifesting as reversible ataxia caused by SIADH-related hyponatremia
por: Habib, Mhd Baraa, et al.
Publicado: (2021) -
A rare case of newly diagnosed diabetes mellitus following COVID-19 infection
por: Motawea, Karam R., et al.
Publicado: (2023)